Human mesenchymal stem cells (hMSCs) are excellent candidates for ex vivo gene transfer and cell therapy in various systems. However, hMSCs are mortal somatic cells, and thus invariably enter an irreversible growth arrest after a finite number of cell divisions in culture. It has been proposed that this is due to telomere shortening. In this study, pGRN145 plasmid containing human telomerase reverse transcriptase (hTRT) was introduced into fetal dermis-derived hMSCs. Single-cell clones positive for telomerase activity and hTRT mRNA were selected and expanded. Single-cell-derived hTRT þ cells could be expanded rapidly in vitro and passaged up to 70 doublings without showing senescence. FACScan flow cytometer showed that hTRT þ cells were positive for CD29, CD44, CD105, and CD166, while CD31, CD45, CD34, vWF, and HLA-DR were negative. Under suitable conditions, hTRT þ cells have the ability of multiple lineage differentiation, including bone, fat, and nerve. Furthermore, transplantation of hTRT þ cells could protect NOD/SCID mice from lethal irradiation. Thus, these cells may be an ideal cell source for promoting hematopoietic recovery after radiotherapy. Bone Marrow Transplantation (2005) 36, 355-365.
Summary:
Human mesenchymal stem cells (hMSCs) are excellent candidates for ex vivo gene transfer and cell therapy in various systems. However, hMSCs are mortal somatic cells, and thus invariably enter an irreversible growth arrest after a finite number of cell divisions in culture. It has been proposed that this is due to telomere shortening. In this study, pGRN145 plasmid containing human telomerase reverse transcriptase (hTRT) was introduced into fetal dermis-derived hMSCs. Single-cell clones positive for telomerase activity and hTRT mRNA were selected and expanded. Single-cell-derived hTRT þ cells could be expanded rapidly in vitro and passaged up to 70 doublings without showing senescence. FACScan flow cytometer showed that hTRT þ cells were positive for CD29, CD44, CD105, and CD166, while CD31, CD45, CD34, vWF, and HLA-DR were negative. Under suitable conditions, hTRT þ cells have the ability of multiple lineage differentiation, including bone, fat, and nerve. Bone marrow is a complex tissue containing stem cells for hematopoiesis and stem cells that are precursors of nonhematopoietic tissues. The precursors of nonhematopoietic tissues are capable of serving as a feeder layer that supports hematopoietic stem cell growth, self-renewing, and differentiation. They were initially named plastic-adherent cells or colony-forming-unit fibroblasts and subsequently named either marrow stromal cells or mesenchymal stem cells (MSCs). MSCs have the ability to support hematopoiesis and differentiate into multiple lineages including bone, cartilage, tendon, muscle, fat, nerve, and stromal cells. [1] [2] [3] [4] [5] [6] [7] Current clinical applications of adult stem cells include the use of allogeneic MSCs to treat osteogenesis imperfecta, a disease with a defect in type I collagen. 8 Koc et al 9 showed that unrelated, human bone marrow-derived, cultureexpanded MSCs may improve the outcome of allogeneic transplantation by promoting hematopoietic engraftment and limiting GVHD in NOD-SCID mice. Owing to this ability, MSCs are of great potential in the context of tissue engineering and cell-based therapy. 10 Recently, our laboratory isolated a cell population from human fetal bone marrow, which were Flk1 þ CD31 À CD34 À and could differentiate into a lot of cell lineages in vitro and in vivo. [11] [12] [13] We also isolated similar MSCs from murine dermis and expanded them for about 30 passages. These cells could promote hematopoiesis when cotransplanted with hematopoietic stem cells. But they gradually lose differentiation potential and become senile after about 30 passages. 14 Somatic cells rarely get established in culture; rather, they undergo cellular and replicative senescence. 15, 16 One hypothesis suggests an intrinsic mechanism that would trigger senescence after a predetermined number of cell generations. This biological clock type of mechanism is based on telomere attrition with each cell division (50-200 bp per cell generation due to the impossibility of DNA polymerase to finish the DNA replication at the end of chromosomes). Cells at a critical telomere length would enter crisis and die. 16 Although the therapeutic potential of MSCs is clear, limited cell number and life span restrict their application, especially when they are to be produced in large scale in a GMP facility to reduce the cost. 9 Zimmermann et al 17 show that telomerase activity is not detectable in human mesenchymal stem cells (hMSCs), although true MSCs might be a very rare subpopulation that has a detection level that is below the sensitivity of their assay. So the relatively low cell passage number for MSCs may be due to their low level of telomerase activity. To circumvent these problems, we isolated MSCs from skin and transfected them with human telomerase reverse transcriptase (hTRE). These cells remain their multipotent differentiation potential and can be passaged up for up to 70 doublings without showing senescence. Furthermore, they can protect damage to hematopoiesis in lethally irradiated mice.
Materials and methods

Isolation and culture of cells from human fetal dermis
Human fetal dermis was obtained from 20 to 22 weeks gestation fetuses after obtaining informed consent as per the academic guidelines on the use of human subjects in research of the Chinese Academy of Medical Sciences & Peking Union Medical College. Skins from abdomen and back were carefully dissected, cut into 0.1-cm 2 pieces, and washed three times in phosphate-buffered saline (PBS). Skin pieces were digested with 0.25% dispase (Sigma, St Louis, MO, USA) for 6-8 h at room temperature, followed by 0.25% trypsin and 0.1% collagenase for 1 h at 371C to completely remove epidermis. Tissue pieces were washed twice with PBS and let through a 40-mM cell strainer. Dissociated cells were centrifuged at 1200 rpm, then cultured in DF12 culture medium containing 40% MCDB medium (Sigma), 2% fetal calf serum (FCS, Gibco Life Technologies, Paisley, UK), 100 U/ml penicillin, and 100 mg/ml streptomycin (Gibco). Cells were cultured at 371C in a 5% CO 2 humidified atmosphere. Once cells were more than 75% confluent, they were detached with 0.25% trypsin-EDTA (Sigma) and replated. Cultured cells were subject to differentiation and phenotype analysis or transfection as described below.
Transfection and selection
The day before transfection, cells were replated in a 24-well plate without antibiotics so that they would reach 90% confluence on the day of transfection. For each well, 50 ml of serum-free OPTI-MEM I Medium (Gibco) containing 1 mg of pGRN145 DNA (Geron Corporation, Menlo Park, CA, USA) was combined with 50 ml of OPTI-MEM I Medium containing 2 ml of LIPOFECTAMINE2000 Reagent (Gibco). The mixture was then added to each well and the plate was gently shaken. After 24 h incubation at 371C, culture medium was changed with fresh medium. After 48 h, transfected cells were plated in medium containing Hygromycin-B (30 mg/ml) for 2-3 weeks; then the concentration was reduced to 10 mg/ml. Single-cellderived clones were selected and expanded, and telomerase activity was analyzed by the telemetric repeat amplification protocol (TRAP). 18, 19 In the following experiment, cells of the passages 15, 30, and 60 were used. The data of passage 30 are shown unless specified otherwise.
Characterization of hTRT þ MSCs
During the log phase of growth, the expanded cells from each single hTRT þ colony were trypsinized, permeabilized For karyotyping analysis, transfected MSCs in the log phase of growth were processed by 0.1 mM cochineal for 6 h at 371C, then digested with 0.25% trypsin-EDTA and subjected to a 15-min colcemid incubation followed by lysis with 0.075 mM KCl and fixation in methanol/acetic acid (3:1). Metaphases were analyzed after QFQ or GTG banding.
Multilineage differentiation of MSCs before and after transfection
hTRT þ MSCs were studied in parallel to their parental cells and cultured under identical differentiation conditions. For osteoblast differentiation, MSCs were cultured at 1 Â 10 4 /cm 2 in DMEM with 10% FBS, 10 mM b-glycerophosphate, 10 À7 M dexamethasone, and 0.2 mM ascorbic acid. After 21 days, differentiation to osteoblasts was shown by Von Kossa staining for calcium phosphate, alkaline phosphatase staining, and reverse transcriptasepolymerase chain reaction (RT-PCR) for osteocalcin. 20 For adipocyte differentiation, MSCs were cultured at 2-3 Â 10 4 /cm in DMEM with 10% FCS, 10 À6 M dexamethasone, 50 mg/ml ascorbic acid, and 100 mg/ml 1-methyl-3-isobutyl-xanthine. After 14 days, Oil-red O staining and RT-PCR for lipoprotein lipase were performed to show adipocyte differentiation. 20 
Tracking of MSCs after transplantation
Eight-to 10-week-old female nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice were bred and maintained under defined flora conditions in individually ventilated (high-efficiency particle-arresting filtered air) sterile microisolator cages. All the experiments were approved by the animal care committee of the Chinese Academy of Medical Sciences & Peking Union Medical College. Before transplantation, harvested cells were stained with the red-orange fluorescent dye CM-DiI (2 mM, Molecular Probes, Eugene, OR, USA) according to the supplier's protocol. Briefly, cells were incubated at 371C for 5 min followed by an additional 15 min at 41C. After labeling, cells were washed with PBS, cultured in 300 ml fresh medium and kept on ice in the dark until being transplanted. Mice were lethally irradiated (350 cGy) from a cesium source (Gammamaster Plus, Gammacell, Leiden, The Netherlands) prior to transplantation. In all, 2 Â 10 6 labeled cells were injected into mice 1 h after irradiation. Recipient NOD/SCID mice were killed by cervical dislocation at different time points after transplantation. Specimens from bone marrow, peripheral blood, liver, spleen, lung, skin, heart, muscle, and brain were collected and embedded in Tissue-TekR OCT. Compound (Sakura Finetek USA, Torrance, CA, USA), quick frozen at À801C, and cut into 4-mm tissue sections. Labeled cells were observed by fluorescence microscopy (Leica, Germany). Specimens were also analyzed for human b 2 -microglobulin by RT-PCR.
Bone marrow and peripheral blood analysis
Peripheral blood samples were obtained from tail and white blood cells were counted with a hemocytometer. Bone marrow cells were collected by flushing femoral shafts and mononuclear cells were counted after trypan blue staining. High proliferative potential colony-forming cell (HPP-CFC) and granulocyte/macrophage colony-forming cell (GM-CFC) assays were performed. Cultures were incubated for 14 days, and then colony formation was determined using a dissecting microscope. HPP-CFCs were scored as colonies 40.5 mm in diameter containing at least 50 000 cells. GM-CFCs were scored as colonies containing 450 cells in response to macrophage colony-stimulating factor (rhu-CSF). For immunohistochemistry, the labeled streptavidin biotin immunoperoxidase system (Dako, Carpinteria, CA, USA) was used to visualize proteins. Cells were fixed with 4% paraformaldehyde at room temperature, and endogenous peroxidase activity was quenched with 3% peroxide for 10 min. Slides were first incubated with primary antibodies, including rabbit polyclonal antibody against CD31 and mouse monoclonal antibody against vWF, CD105, collagen type I, collagen type IV, GFAP or NF (1:150), for 30 min, followed by biotin-labeled anti-rabbit or antimouse IgG antibody and peroxidase-conjugated streptavidin, and finally visualized with diaminobenzidine staining (Sigma).
Assay for the supportive effects of hTRT þ MSCs on hematopoietic recovery in lethally irradiated NOD/SCID mice To study the supportive effect of TRT þ MSCs on hematopoiesis, 2 Â 10 6 hTRT þ MSCs were injected into recipient mice (n ¼ 25) 1 h postirradiation (350 cGy). As control, SCF was injected at a dosage of 100 mg/kg via tail vein (n ¼ 10). White blood cells (WBCs) in peripheral blood were counted at 1, 3, 5, 7, 14, 21, and 28 days after transplantation. At days 1, 3, 7, 14, 21, and 28, mice from the hTRT þ MSCs group were sacrificed and bone marrows were obtained for mononuclear cell counting and CFU-GM culture. Similar assay was performed for the SCF group at days 1 and 3, as no mice survived more than 7 days in the SCF group.
Safety evaluation of single-dose hTRT
þ MSCs in the 6-month study For long-term safety study, 2 Â 10 6 cells were injected into NOD/SCID mice by tail vein. Recipient NOD/SCID mice were killed by cervical dislocation 6 months after transplantation. Specimens from different tissues were collected. Sections (5 mm) of paraffin-embedded tissue samples were examined by light microscopy after staining with hematoxylin and eosin for tumorogenesis evaluation. Laboratory examinations for serum protein, uric acid, lymphocyte ratio, erythrocyte count, hematocrit, hemoglobin, albumin, A/G ratio, cholesterol (esterified, total, and free), phospholipids, triglycerides, cholinesterase activity, and creatinine were performed in routine methods by the hospital.
Results
Selection of the transfected MSCs
Plasmid containing hTRT was transfected into MSCs by lipofectin 2000. After 48 h, selected medium containing 30 mg/ml Hygromycin-B was added into transfected cells. Hygromycin-B concentration was reduced to 10 mg/ml when the number of live cells decreased markedly after 2 weeks. Several days later, cell clones were observed. Individual adherent cells were identified. Wells containing Plasticity of clonal mesenchymal stem cell Z Zhao et al more than one colony were discarded. Then, a single colony was harvested by trypsinization and replated. An individual clone was passaged and analyzed by TRAP for telomerase activity, and RT-PCR for hTRT mRNA. Those positive for telomerase activity and hTRT mRNA were collected and referred to hTRT þ clones (Figure 1 ). MSCs was analyzed by FACS. As shown in Figure 3 , hTRT þ MSCs expressed CD105, CD29, CD44; however, they did not express hematopoietic markers CD34, CD45, GlyA, and endothelial markers CD31 and vWF. HLA-DR was negative too (Figure 3a) . FACS showed that 90.90% cells were at G0/G1, 2.01% at G2/M, and 7.08% at S phases of cell cycle (Figure 3b ). The immunophenotype difference between hTRT þ and hTRT À MSCs is shown in Table 1 . Cytogenetic analysis of hTRT þ MSCs at 30th passage (n ¼ 4) showed a normal karyotype (Figure 4 ).
Biological characteristics of hTRT
þ MSCs hTRT þ MSCs were analyzed for cell morphology, growth pattern, and cell cycle status. These cells displayed fibroblast-like morphology (Figure 2). Six hTRT þ clones were expanded for more than 70 passages, almost 30 passages longer than their parent MSCs. The doubling time of hTRT þ MSCs cells was similar to their hTRT À parent MSCs, about 30 h. The immunophenotype of hTRT
Multilineage differentiation of hTRT
þ MSCs hTRT þ MSCs could differentiate into cells with morphologic and phenotypic characteristics of adipocyte, osteocyte, and glia under conditions that favored the multilineage differentiation of MSCs. In osteocyte differentiation, hTRT þ MSCs formed aggregates and calcium deposit in 3 weeks. Von Kossa staining for calcium phosphate and increased alkaline phosphatase staining identified the differentiation of osteocytes; this was further confirmed by RT-PCR for osteocalcin (Figure 5a-c) . In adipocyte differentiation, lipid-laden cells appeared in hTRT þ MSCs about 3 or 5 days later. After two weeks, more than 70% of cells differentiated into adipocyte that stained with Oil-red O. These cells also expressed lipoprotein lipase as shown by RT-PCR (Figure 5d-f) . hTRT þ MSCs underwent neural differentiation when cultured in suitable condition that consist of 5% FCS, 5% HS, 20 nM pregnendione, 0.5 mM RARa, 0.001% bmercaptoethanol, and 25 mg/ml insulin. After 7 days, neural-like cells appeared; they were positive for GFAP, a specific marker of glia, and NF, a marker of neuron by immunohistochemistry (Figure 5g Plasticity of clonal mesenchymal stem cell Z Zhao et al tissues, such as bone marrow, peripheral blood, lung, liver, and skin, but was absent in brain, muscle, spleen, and heart. However, only at 4, 12, 24, and 72 h could we find donor cells in bone marrow and peripheral blood, as no red-orange fluorescence was seen in these tissues 72 h later. To exclude the possibility that this fluorescence was a residue of dead donor cells engulfed by recipient macrophages, we detected human b2-microglobulin in these tissues by RT-PCR. Engulfed donor cells would be decomposed in macrophages and their genome would also Table 2 ). To determine whether the hTRT þ MSCs in the organs of NOD/SCID mice were still viable, single-cell suspensions from dermis, lung, liver, spleen, muscle, bone marrow, and peripheral blood were cultured in expansion medium. Fibroblast-like cells could be cultured from the lung, dermis, liver, muscle, and bone marrow, but not from spleen and peripheral blood. After 4 weeks' culture, more than 50% of cultured cells from lung, dermis and liver were positive for human CD44 and LAMP-1, indicating their human origin. From their morphology and their ability to adhere to the flask bottom, we concluded that at least some of the infused cells retained their MSC nature. However, no human cells were detected in muscle. About 40% cells were positive for human CD44 and LAMP-1 in cultured bone marrow cells within 72 h after injection, but no human cells could be detected later (data not show). These results were confirmed using RT-PCR for human b2-microglobulin.
Role of hTRT
þ MSCs on hematopoietic recovery in lethally irradiated NOD/SCID mice To study the supportive effect of TRT þ MSCs on hematopoiesis, 2 Â 10 6 labeled cells were injected into recipient mice (n ¼ 25) 1 h post irradiation (350 cGy). By day 7, all the mice in the SCF group died. In comparison, the 30-day survival rate of MSCs group was 90% (9/10); only one died at day 14 postirradiation. Except for three mice that were killed at day 30 post irradiation, all the others (n ¼ 6) were alive. Table 1 Immunophenotypes of cultured hTRT + and hTRT Plasticity of clonal mesenchymal stem cell Z Zhao et al For WBC, there was no significant difference between MSCs and control groups for the first 7 days after irradiation. However, in the MSCs group, WBC levels increased from day 7. After 4 weeks, WBCs nearly returned to the level before irradiation. Similarly, the bone marrow cells decreased rapidly in the first week post irradiation and reached their lowest at day 7. They began to increase gradually and had almost returned to preirradiation level at day 28. Although decrease in CFU-GM and HPP-CFU was observed post irradiation, CFU-GM and HPP-CFU levels increased gradually. By day 28, CFU-GM and HPP-CFU counts almost returned to preirradiation level ( Figure 7) .
In SCF and control groups, however, the bone marrow cells, CFU-GM, HPP-CFU, and WBC level in peripheral blood decreased rapidly in the first week post irradiation and never recovered.
Safety profile of transplanted hTRT þ MSCs
We did not detect donor-derived tumor in any of the animals after 6 months. Also, no abnormalities in serum protein, uric acid, lymphocyte ratio, erythrocyte count, hematocrit, hemoglobin, albumin, A/G ratio, cholesterol (esterified, total and free), phospholipids, triglycerides, cholinesterase activity and creatinine were observed (data not shown). Although Conget showed that human MSC can be detected in mouse bone marrow for as long as 1 year after human MSC infusion, we did the 6-month safety test according to the requirement of the authorities for the new medical product. 21 
Discussion
The data presented in this study demonstrate that hTRT þ MSCs have a longer lifespan than hTRT À MSCs and could promote hematopoiesis after irradiation in NOD/SCID mice. Somatic cells have a limited lifespan in vivo as well as invitro and retire into senescence after a predictable number of cellular divisions. Telomeres, specialized end portions of eukaryotic chromosomes, shorten as a linear function of increasing cellular division, and a critically short telomere length triggers the onset of senescence. Previous studies have shown that telomerase is overexpressed in cancer, immortal cells, and germ cells, where it compensates for telomere shortening and thus stabilizes telomere length. The relationship between expression of telomerase and telomere length stabilization and the extension of the life span of the human cell have been reported. 21, 22 MSCs, or marrow stromal cells, are multipotential cells. 2, 23 Stromal cells of the marrow microenvironment and their associated biosynthetic products provide the physical framework within which hematopoiesis occurs, synthesize or present growth-stimulatory and growthinhibitory factors, produce numerous extracellular matrix ligands, and express a broad repertoire of adhesion molecules that serve to mediate hematopoietic stem cell homing and to transmit regulatory signals. 24, 25 Marrow stromal cells generated ex vivo from patients with hematological malignancies who had undergone autologous or allogeneic transplantation show a significant impairment of their proliferative and differentiative potential as well as impairment of their ability to support the growth of allogeneic CD34 þ cells. 26 When marrow mononuclear cells were cultured in vitro, only 34% of the patients generated a confluent or subconfluent stromal layer, demonstrating the substantial microenvironment damage induced by chemoradiotherapy. 27 Based on observations, ex vivo expanded MSCs may be used to replace the marrow microenvironment damaged by myeloablative chemotherapy. There is a growing interest in cotransplantation of allogeneic stromal and hematopoietic progenitors to improve the patient outcome after allogeneic transplantation. 28 It is thought that these progenitors give rise to mesenchymal cells in the marrow that fabricate the connective tissue scaffolding, and produce cytokines, chemokines, and extracellular matrix proteins that regulate hematopoietic homing and proliferation. 7, 29, 30 A number of preclinical animal models of stromal cell transplantation have been established to support hematopoietic engraftment, including using human fetal lung-derived MSCs. [31] [32] [33] Both autologous and allogeneic human marrow stromal cells were shown to improve the quantity and duration of human hematopoietic engraftment in a preimmune sheep model. 34 Angelopoulou et al 35 recently reported that cotransplantation of human MSCs enhanced myelopoiesis and megakaryopoiesis in NOD-SCID mice transplanted with the limiting doses of peripheral blood CD34 þ cells. Our results extend these observations to dermis-derived MSCs transfected with telomerase. We performed this study based on two hypotheses. First, in case of autologous transplantation for hematopoietic malignancy, skin tissue may be a valuable source for MSCs as it is less contaminated by leukemia cells. Secondly, transfection of telomerase may provide more MSCs cells and promote MSCs' differentiation potential, which will give rise to more components of the marrow microenvironment needed for hematopoiesis. Liu et al 36 showed that murine MSCs lacking telomerase lose multipotency and the capacity to differentiate. The MSCs isolated from telomerase knockout (mTRÀ/À) mice failed to differentiate into adipocytes and chondrocytes, even at early passages. Recently, Burns et al 37 reported that long term expression of hTRT in MSC can result in tumorgenesis. This did not occur in our experiment. This difference may be the result of the different vectors used. Tumorigenic transformation in Burns' report may have been caused by the improper insertion of a retroviral vector, which made the genome more vulnerable to unwanted changes, and thereby gradually lead to activation of oncogenes. 38 The mechanism of hematopoietic support in NOD-SCID mice by human MSCs is not clear at this time. Noort et al 33 did not find any impact of fetal lung MSCs on the homing of a coinfused CD34 þ cell. It is possible that coinfused MSCs provide secreted human cytokines and hematopoietic niches to support human cells by direct contact. However, evidence of low-level bone marrow engraftment of MSCs was also found in dogs and nonhuman primates after intravenous infusion. 39, 40 In our study, we also found that infused MSCs were absent in one marrow after 7 days. So it is possible that the major role of MSCs during cotransplantation is mediated by secreted proteins that have systemic effects, rather than provide niches for hematopoietic stem cells. Thus, bone marrow location of MSCs engraftment may not be a prerequisite for their role in supporting hematopoiesis. Another explanation is that infused MSCs may prevent the hematopoietic stem cells from apoptosis by unknown mechanisms. In our lab, we found that transplantation of MSCs after total abdominal irradiation can alleviate apoptosis of intestinal musoca cells (unpublished data).
Here, we showed that hTRT þ MSCs and hTRT À MSCs have the same morphology, immunephenotype, multiple differentiation ability, and normal karyotype. SCF administrated before radiation could protect the hematopoietic system by increasing the cell cycling of bone marrow cells into the late S phase; and the late S phase has been shown to be the most radioresistance phase of the cell cycle. 41, 42 Here, we found that injected SCF postirradiation did not have any radioprotective effect, while MSCs transplantation could protect NOD/SCID mice from lethal radiation damage. This reduction in mortality appears to result from prompt hematopoietic recovery in the MSCstreated mice. Bone marrow primitive (HPP-CFC) and mature (GM-CFC) progenitors as well as mononuclear 30 cells in MSCs group increased markedly above those in SCF-treated mice by day 5. SCF-treated mice died within 1 week after irradiation while almost all MSCs-treated mice survived from irradiation. In summary, it was found that MSCs can have an extended lifespan by introducing human telomerase into them. Also transfected MSCs maintain the characteristics of multipotent stem cells and have hematopoiesis protective effect in NOD/SCID mice after lethal irradiation. Moreover, clones of single hTRT þ cell were selected and expanded. Thus, we can study the biologcal characteristics of MSCs at single cell level. Table 2 Distribution of MSCs in NOD/SCID mice Organs 4h 24h 3th day 7th day 14th day 28th day F P F P F P F P F P F P Plasticity of clonal mesenchymal stem cell Z Zhao et al
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